Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR+8.3%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+8.3%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 2.67% |
| 2023 | 53.69% |
| 2022 | -173.79% |
| 2021 | -47.03% |
| 2020 | 79.97% |
| 2019 | 1.79% |
| 2018 | -7901.31% |
| 2017 | 99.18% |
| 2016 | -49.38% |
| 2015 | -50528.28% |